To access any content or REGISTER in less than 3 minutes.
Register
Menu
Are you medical worker?
No, visit servier-me.com
Your account was deleted
Please login to MyServier to continue reading this content
or sign in without a password
No account yet?
You already have an account associated with this email address. Please log in to continue.
or sign in without a password
No account yet?

ADD2DIA: synergy between SGLT2i and Gliglazide MR

13.09.2026
9

Watch the ADD2DIA overview on the real-world clinical effectiveness of adding an SGLT2 inhibitor to gliclazide MR-based therapy in T2DM.

Content exclusive for connected users. Please sign in or register to access more.

Already have an account?

New here?

Create account